0001104659-21-143597.txt : 20211124 0001104659-21-143597.hdr.sgml : 20211124 20211124163032 ACCESSION NUMBER: 0001104659-21-143597 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211123 FILED AS OF DATE: 20211124 DATE AS OF CHANGE: 20211124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENKOWITZ MICHAEL CENTRAL INDEX KEY: 0001673232 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 211447233 MAIL ADDRESS: STREET 1: C/O UNITED THERAPEUTICS CORP STREET 2: 1040 SPRING STREET CITY: SILVER SPRING STATE: MD ZIP: 20910 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 tm2133880-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-11-23 0 0001082554 UNITED THERAPEUTICS Corp UTHR 0001673232 BENKOWITZ MICHAEL C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 0 1 0 0 President and COO Common Stock 2021-11-23 4 M 0 4000 61.06 A 6235 D Common Stock 2021-11-23 4 D 0 4000 201.58 D 2235 D Share Tracking Award 61.06 2021-11-23 4 M 0 4000 0 D 2014-03-15 2023-03-15 Common Stock 4000 14400 D This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. /s/ John S. Hess, Jr. under Power of Attorney 2021-11-24